Literature DB >> 35689980

Distinguishing CNS neurosarcoidosis from multiple sclerosis and an approach to "overlap" cases.

Fiona Chan1, D Sean Riminton2, Sudarshini Ramanathan3, Stephen W Reddel4, Todd A Hardy5.   

Abstract

Neurosarcoidosis is an important diagnosis to exclude in the work-up for suspected multiple sclerosis (MS). The distinction between the two conditions is usually possible due to characteristic clinical manifestations, magnetic resonance imaging (MRI) findings, and the results of other supportive investigations such as CT-PET. Definitive diagnosis can be made by histopathological examination, but this is not always practical. Misdiagnosis can occur when the clinical characteristics and MRI findings of both conditions overlap. Those patients with characteristic findings of MS but extraneural histopathological evidence of sarcoidosis are a particularly difficult diagnostic group. Diagnostic clarity is essential to inform treatment, especially as certain treatments for one disorder can exacerbate the other. This article summarises the clinical, laboratory and radiological findings that aid the clinician in distinguishing between the two conditions. It also discusses the literature on the potential for sarcoidosis and MS to co-exist in some patients, and how to approach the treatment of these "overlap" patients.
Copyright © 2022 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Co-exist; MS; Management; Mimic; Neurosarcoidosis; Nosology

Mesh:

Year:  2022        PMID: 35689980     DOI: 10.1016/j.jneuroim.2022.577904

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.221


  1 in total

1.  Multiple sclerosis in sarcoidosis patients: Two case reports.

Authors:  Masoud Etemadifar; Armin Mehri; Nahad Sedaghat; Mehri Salari; Parsa Tavassoli Naini
Journal:  Clin Case Rep       Date:  2022-09-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.